Alemtuzumab: Evidence for Its Potential in Relapsing–remitting Multiple Sclerosis
Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s32687
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2013
Authors
Publisher
Informa UK Limited